RxNorm 1659152

alirocumab

RxNorm Semantic Concepts

RxNorm semantic concepts for the RxCUI 1659152 unique identifier include: alirocumab (7254458), Alirocumab (8243973), Alirocumab (substance) (8243974), Alirocumab-containing product (10795921) and Product containing alirocumab (medicinal product) (10809814).

RxNorm Atom ID: 7254458 - Ingredient
alirocumab

RXCUI:
1659152 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
7254458 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
alirocumab - Description of concept identifier
Term Type (TTY):
IN - Term type in source with name and description
Term Type Name:
Ingredient - Name of term type in source
Term Type Description:
A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). - Description of term type in source
Code:
1659152 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
RxNorm to UNII Crosswalk:
PP0SHH6V16 - ALIROCUMAB (protein) - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
Source:
RXNORM - Concept source abbreviation
Source Name:
RxNorm Vocabulary - The official name for a source
Source Version:
20AA_250707F - The source version
Source Date:
July 07, 2025 - RxNorm data last updated
Source License Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
Source Content Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
Source Short Name:
RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 8243973 - Designated preferred name
Alirocumab

RXCUI:
1659152 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
8243973 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
Alirocumab - Description of concept identifier
Term Type (TTY):
PT - Term type in source with name and description
Term Type Name:
Designated preferred name - Name of term type in source
Term Type Description:
- Description of term type in source
Code:
715186005 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
- Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
RxNorm to UNII Crosswalk:
PP0SHH6V16 - ALIROCUMAB (protein) - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
Source:
SNOMEDCT_US - Concept source abbreviation
Source Name:
US Edition of SNOMED CT - The official name for a source
Source Version:
2025_01_31 - The source version
Source Date:
July 07, 2025 - RxNorm data last updated
Source License Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source license contact information
Source Content Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source content contact information
Source Short Name:
US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 8243974 - Full form of descriptor
Alirocumab (substance)

RXCUI:
1659152 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
8243974 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
Alirocumab (substance) - Description of concept identifier
Term Type (TTY):
FN - Term type in source with name and description
Term Type Name:
Full form of descriptor - Name of term type in source
Term Type Description:
- Description of term type in source
Code:
715186005 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
- Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
RxNorm to UNII Crosswalk:
PP0SHH6V16 - ALIROCUMAB (protein) - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
Source:
SNOMEDCT_US - Concept source abbreviation
Source Name:
US Edition of SNOMED CT - The official name for a source
Source Version:
2025_01_31 - The source version
Source Date:
July 07, 2025 - RxNorm data last updated
Source License Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source license contact information
Source Content Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source content contact information
Source Short Name:
US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 10795921 - Designated preferred name
Alirocumab-containing product

RXCUI:
1659152 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
10795921 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
Alirocumab-containing product - Description of concept identifier
Term Type (TTY):
PT - Term type in source with name and description
Term Type Name:
Designated preferred name - Name of term type in source
Term Type Description:
- Description of term type in source
Code:
781355008 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
- Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
RxNorm to UNII Crosswalk:
PP0SHH6V16 - ALIROCUMAB (protein) - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
Source:
SNOMEDCT_US - Concept source abbreviation
Source Name:
US Edition of SNOMED CT - The official name for a source
Source Version:
2025_01_31 - The source version
Source Date:
July 07, 2025 - RxNorm data last updated
Source License Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source license contact information
Source Content Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source content contact information
Source Short Name:
US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 10809814 - Full form of descriptor
Product containing alirocumab (medicinal product)

RXCUI:
1659152 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
10809814 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
Product containing alirocumab (medicinal product) - Description of concept identifier
Term Type (TTY):
FN - Term type in source with name and description
Term Type Name:
Full form of descriptor - Name of term type in source
Term Type Description:
- Description of term type in source
Code:
781355008 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
- Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
RxNorm to UNII Crosswalk:
PP0SHH6V16 - ALIROCUMAB (protein) - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
Source:
SNOMEDCT_US - Concept source abbreviation
Source Name:
US Edition of SNOMED CT - The official name for a source
Source Version:
2025_01_31 - The source version
Source Date:
July 07, 2025 - RxNorm data last updated
Source License Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source license contact information
Source Content Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source content contact information
Source Short Name:
US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Patient Education

Alirocumab Injection


Alirocumab injection is used along with diet, alone or in combination with other cholesterol-lowering medications (HMG-CoA reductase inhibitors [statins] or ezetimibe [Zetia, in Liptruzet, in Vytorin]), in adults who have familial heterozygous hypercholesterolemia (an inherited condition in which cholesterol cannot be removed from the body normally) to decrease the amount of low-density lipoprotein (LDL) cholesterol ('bad cholesterol') in the blood. It is also used in adults with cardiovascular disease to lower the risk of stroke, heart attack, or serious or life-threatening chest pain. Alirocumab injection is also used with other medications to treat homozygous familial hypercholesterolemia (HoFH; an inherited condition in which cholesterol cannot be removed from the body normally) in adults to decrease LDL cholesterol. Alirocumab injection is in a class of medications called proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor monoclonal antibodies. It works by blocking the production of LDL cholesterol in the body therefore decreasing the amount of cholesterol that may build up on the walls of the arteries. Accumulation of cholesterol along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and, therefore, the oxygen supply to your heart, brain, and other parts of your body.
[Learn More]


* Please review the disclaimer below.